• Je něco špatně v tomto záznamu ?

Mouse bioassay for in vivo screening of oestrogen and progesterone antagonists

Skarda J, Köhlerová E.

. 2006 ; 53 (3) : 145-153.

Jazyk angličtina Země Německo

Perzistentní odkaz   https://www.medvik.cz/link/bmc07522775
E-zdroje Online

NLK Medline Complete (EBSCOhost) od 1998-02-01 do 2007-12-31
Wiley Online Library (archiv) od 1997 do 2007

This study tested and compared the anti-proliferative and proliferative activities of two anti-oestrogens and three anti-progestins on four separate mouse model systems: young intact and adult ovariectomized (OV-X) females, and young intact and adult castrated males. Pure steroidal anti-oestrogen ICI 182,780 (ICI) decreased mammary and uterine growth stimulated by endogenous hormones in young intact females and by exogenous hormones [progesterone (Prog), 17beta-oestradiol (E) or E plus Prog] in both young intact and adult ovariectomized (OV-X) females. Non-steroidal anti-oestrogen EM-800 (EM), on the other hand, had no effect on mammary and uterine growth stimulated by endogenous hormones in young intact females and in adult OV-X females. Uterine growth was even stimulated by EM alone, and a combination of EM plus Prog not only stimulated uterine growth but also mammary growth (an oestrogenic agonistic activity). However, EM showed anti-oestrogenic activities in both mammary and uterine tissues in females treated with E or E plus Prog. In males, ICI and EM decreased mammary growth stimulated by exogenous hormones (E or E plus Prog) in both young intact and adult castrated animals. In young intact, but not in adult castrated males, ICI increased seminal vesicle growth affected by both endogenous and exogenous (Prog, E or E plus Prog) hormones. EM, on the other hand, decreased seminal vesicle weights in E or E plus Prog and increased its weights in Prog-treated young intact males. Thus, under certain conditions EM possess mixed agonist and antagonist activity in the mammary gland, uterus and seminal vesicles. Norethindrone acetate (NA)-stimulated mammary growth was decreased by anti-progestins onapristone (ON), RU 46556 (RU), and RU 38486 (MI) by 34-59% in females and by 35-93% in males. Uterine weights of NA-treated females were decreased by ON and RU by 29-55% but not by MI. In NA-treated young intact males, seminal vesicle weights were stimulated by RU (by 63%) and not affected by ON and MI. In NA-treated adult castrated males, seminal vesicle weights were decreased by ON, increased by RU and not affected by MI. The results obtained in these and our earlier studies show clearly that mouse four-model systems could serve as in vivo tool for the detection of steroid hormone agonist and antagonist activities of natural and man-made chemicals.

000      
00000naa 2200000 a 4500
001      
bmc07522775
003      
CZ-PrNML
005      
20111210134533.0
008      
090507s2006 gw e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Škarda, Josef, $d 1939- $7 jo20000080432
245    10
$a Mouse bioassay for in vivo screening of oestrogen and progesterone antagonists / $c Skarda J, Köhlerová E.
314    __
$a Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Vídenská 1083, 142 20 Prague 4, Czech Republic
520    9_
$a This study tested and compared the anti-proliferative and proliferative activities of two anti-oestrogens and three anti-progestins on four separate mouse model systems: young intact and adult ovariectomized (OV-X) females, and young intact and adult castrated males. Pure steroidal anti-oestrogen ICI 182,780 (ICI) decreased mammary and uterine growth stimulated by endogenous hormones in young intact females and by exogenous hormones [progesterone (Prog), 17beta-oestradiol (E) or E plus Prog] in both young intact and adult ovariectomized (OV-X) females. Non-steroidal anti-oestrogen EM-800 (EM), on the other hand, had no effect on mammary and uterine growth stimulated by endogenous hormones in young intact females and in adult OV-X females. Uterine growth was even stimulated by EM alone, and a combination of EM plus Prog not only stimulated uterine growth but also mammary growth (an oestrogenic agonistic activity). However, EM showed anti-oestrogenic activities in both mammary and uterine tissues in females treated with E or E plus Prog. In males, ICI and EM decreased mammary growth stimulated by exogenous hormones (E or E plus Prog) in both young intact and adult castrated animals. In young intact, but not in adult castrated males, ICI increased seminal vesicle growth affected by both endogenous and exogenous (Prog, E or E plus Prog) hormones. EM, on the other hand, decreased seminal vesicle weights in E or E plus Prog and increased its weights in Prog-treated young intact males. Thus, under certain conditions EM possess mixed agonist and antagonist activity in the mammary gland, uterus and seminal vesicles. Norethindrone acetate (NA)-stimulated mammary growth was decreased by anti-progestins onapristone (ON), RU 46556 (RU), and RU 38486 (MI) by 34-59% in females and by 35-93% in males. Uterine weights of NA-treated females were decreased by ON and RU by 29-55% but not by MI. In NA-treated young intact males, seminal vesicle weights were stimulated by RU (by 63%) and not affected by ON and MI. In NA-treated adult castrated males, seminal vesicle weights were decreased by ON, increased by RU and not affected by MI. The results obtained in these and our earlier studies show clearly that mouse four-model systems could serve as in vivo tool for the detection of steroid hormone agonist and antagonist activities of natural and man-made chemicals.
650    _2
$a financování organizované $7 D005381
650    _2
$a zvířata $7 D000818
650    _2
$a biotest $7 D001681
650    _2
$a kastrace $7 D002369
650    _2
$a antagonisté estrogenu $x farmakologie $7 D004965
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mléčné žlázy zvířat $x růst a vývoj $x účinky léků $7 D008321
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C3H $7 D008809
650    _2
$a modely u zvířat $7 D023421
650    _2
$a velikost orgánu $x účinky léků $7 D009929
650    _2
$a progesteron $x antagonisté a inhibitory $7 D011374
650    _2
$a semenné váčky $x růst a vývoj $x účinky léků $7 D012669
650    _2
$a uterus $x růst a vývoj $x účinky léků $7 D014599
700    1_
$a Köhlerová, E. $7 _AN034088
773    0_
$w MED00007305 $t Journal of veterinary medicine. Series A, Physiology, pathology, clinical medicine $g Roč. 53, č. 3 (2006), s. 145-153 $x 0931-184X
910    __
$a ABA008 $b x $y 9
990    __
$a 20090506084234 $b ABA008
991    __
$a 20090702152851 $b ABA008
999    __
$a ok $b bmc $g 650867 $s 504031
BAS    __
$a 3
BMC    __
$a 2006 $b 53 $c 3 $d 145-153 $i 0931-184X $m Journal of veterinary medicine. Series A $x MED00007305
LZP    __
$a 2009-B2/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...